E676-0422 Screening compound: 5-chloro-N~2~-[2-(dimethylamino)ethyl]-N~2~-(6-fluoro-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide

E676-0422 Screening compound: 5-chloro-N~2~-[2-(dimethylamino)ethyl]-N~2~-(6-fluoro-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide
E676-0422 Screening compound: 5-chloro-N~2~-[2-(dimethylamino)ethyl]-N~2~-(6-fluoro-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E676-0422
5-chloro-N~2~-[2-(dimethylamino)ethyl]-N~2~-(6-fluoro-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E676-0422

Molecular Formula

C16H15ClFN3OS2 (C16 H15 ClFN3 OS2)

Compound Name

5-chloro-N~2~-[2-(dimethylamino)ethyl]-N~2~-(6-fluoro-1,3-benzothiazol-2-yl)-2-thiophenecarboxamide

IUPAC name

5-chloro-N-[2-(dimethylamino)ethyl]-N-(6-fluoro-13-benzothiazol-2-yl)thiophene-2-carboxamide

SMILES

CN(C)CCN(C(c(s1)ccc1Cl)=O)c1nc(ccc(F)c2)c2s1

InChI

InChI=1S/C16H15ClFN3OS2/c1-20(2)7-8-21(15(22)12-5-6-14(17)23-12)16-19-11-4-3-10(18)9-13(11)24-16/h3-6,9H,7-8H2,1-2H3

InChI Key

GMVWZIUUIGCMIY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11984721

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

383.9

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.633

Distribution Coefficient, logD

4.225

Water Solubility, LogSw

-4.71

Polar Surface Area

30.259

Acid Dissociation Constant (pKa)

23.37

Base Dissociation Constant (pKb)

7.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

E676-0422 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E676-0422 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E676-0422?
Check Price and Availability of E676-0422, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E676-0422 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E676-0422
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E676-0422
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E676-0422 available by request